BP PLC $0.25 (BP.L)

Key Updates

BP PLC (BP.L) shares have declined 2.03% since the last report on 01 August 2026, trading at $541.30 as of 01 October 2026. This pullback follows the strong recovery rally documented in prior reports, bringing the stock off its recent highs while still maintaining a substantial 25.07% YTD gain. The current price represents a modest consolidation phase after the sharp ~15.5% surge in late July that reversed a five-report losing streak. Since the previous analysis, four news items have emerged, most notably reports that BP is weighing the sale of its Brazilian biofuels business and a bullish Wall Street call suggesting the oil giant is now a buy after lagging rivals through two energy crises.

Current Trend

The medium-term trend remains firmly positive, with the stock up 25.07% YTD despite the recent 5.33% decline over the past five days and a 10.72% drop over six months. The 1-month price movement shows a flat 0.00% change, indicating the stock has been rangebound over the past month. The recent pullback of 2.03% since the last report suggests profit-taking after the sharp July rally. Key support appears to be forming around the $539-540 level, which corresponds to the late-July surge point, while resistance is likely near the $552-555 area where the stock peaked in early August. The 6-month decline of 10.72% versus the 25.07% YTD gain highlights that most of the year's appreciation occurred in the first half, with the stock having given back some gains during the summer months before the July reversal.

Investment Thesis

The investment thesis for BP remains constructive, supported by multiple factors. Barclays analyst Lydia Rainforth highlighted BPX (BP's energy business) as central to BP's growth strategy following a meeting with BPX CEO Kyle Koontz, suggesting confidence in this division's role in driving future performance. Additionally, Bloomberg reports that BP is weighing the sale of its Brazilian biofuels business, which could represent portfolio optimization and capital recycling. A Morningstar analysis dated 30 September 2026 provides current fundamental assessment, while a separate Morningstar piece from 23 September notes that one Wall Street giant now recommends buying BP after the company lagged leading rivals through two energy crises — suggesting potential catch-up upside. The company's YTD performance of 25.07% demonstrates meaningful shareholder value creation, though the recent pullback and mixed six-month performance warrant monitoring.

Thesis Status

The investment thesis remains intact but is showing signs of maturation. The stock's 25.07% YTD gain confirms the recovery narrative established in the 29 July report, where shares surged 15.48% and erased a five-report losing streak. The current 2.03% decline since the last report represents a normal consolidation within an uptrend rather than a thesis break. The fundamental drivers — BPX growth strategy, potential divestiture of Brazilian biofuels, and renewed Wall Street interest — all support the bull case. However, the 10.72% six-month decline and 5.33% five-day drop indicate the stock is not immune to broader energy sector volatility. The thesis status is best characterized as "constructive with near-term consolidation," as the core growth narrative remains supported while the stock digests recent gains.

Key Drivers

• BPX growth strategy: Barclays analyst commentary identifies BP's energy business as central to growth strategy, providing fundamental support for the investment case. Source
• Brazilian biofuels divestiture: Bloomberg reports BP is weighing the sale of its Brazilian biofuels business, which could streamline operations and unlock capital. Source
• Wall Street endorsement: A major Wall Street firm has issued a buy recommendation, citing BP's underperformance through two energy crises as creating catch-up potential. Source
• Fundamental analysis update: Morningstar's latest analysis (30 September 2026) provides an updated view on BP's valuation and prospects. Source

Technical Analysis

BP is trading at $541.30, down 1.47% on the day and 5.33% over five days, reflecting a short-term corrective phase. The stock remains 25.07% higher YTD, confirming the dominant uptrend. Key support is identified at the $539-540 zone, which aligns with the late-July surge level and the 1-month flat performance suggests buyers are defending this area. Resistance is likely at $552.50 (the level at the last report) and potentially higher toward the $570-580 area if the stock resumes its advance. The 6-month decline of 10.72% versus the strong YTD gain indicates the stock has formed a base after earlier weakness, with the July rally establishing a higher low. The current pullback appears to be a healthy retracement within the broader uptrend, with the flat 1-month performance suggesting consolidation rather than distribution.

Bull Case

• Strong YTD performance of 25.07% demonstrates the company's ability to create shareholder value despite challenging energy market conditions. Source
• BPX is identified as central to BP's growth strategy by Barclays, indicating a clear strategic direction for future value creation. Source
• Potential sale of Brazilian biofuels business could streamline operations, reduce complexity, and unlock capital for higher-return investments. Source
• Wall Street buy recommendation after underperformance through two energy crises suggests potential for catch-up gains relative to rivals. Source
• The stock's ability to maintain a 25% YTD gain despite a 10.72% six-month decline indicates resilience and a strong first-half performance that anchors the year's returns. Source

Bear Case

• Recent price weakness of 5.33% over five days and 2.03% since the last report suggests momentum is fading and profit-taking is underway. Source
• The 10.72% six-month decline indicates the stock has underperformed over a longer horizon, raising questions about sustained demand for energy assets. Source
• BP has lagged its leading rivals through two energy crises, suggesting structural competitive disadvantages that may persist. Source
• The Brazilian biofuels sale, while potentially positive, also signals divestment activity that could indicate challenges in certain business segments. Source
• The flat 1-month performance and negative 5-day momentum suggest the stock may struggle to break above resistance levels without fresh catalysts. Source